Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma

J Dtsch Dermatol Ges. 2024 Apr;22(4):587-589. doi: 10.1111/ddg.15340. Epub 2024 Feb 20.

Authors

Inga Hansen¹, Christoffer Gebhardt¹, Nina Booken¹, Stefan W Schneider¹

Affiliation

¹ Klinik und Poliklinik für Dermatologie und Venerologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg.

PMID: 38379256
DOI: 10.1111/ddg.15340

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Hemangiosarcoma*
Humans
Pemphigoid, Bullous* / chemically induced
Pemphigoid, Bullous* / drug therapy

Substances

dupilumab
Antibodies, Monoclonal, Humanized